BNR BNR
Company Profile ↓Company Overview
BNR (BNR) is a publicly traded company listed on with a market capitalization of $960.87M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.08.
Recent Developments
- Dec 2025 Revenue of $539.57M (+4.6% YoY); net profit $-55.35M.
- Trailing 12 Months Year-on-year growth — revenue +4.6%.
- 5-Year Trend Long-term compounding — revenue CAGR -1.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -1.42% |
| 1 Year: | 4.60% |
Stock Price Performance
| 1 Year: | +44.32% |
| 6 Months: | -73.57% |
| 3 Months: | -47.84% |
| 1 Month: | -17.36% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)42.92 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -1.4% CAGR over 5 years.
- Trading 78.4% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 133.08M | 148.55M | 131.62M | 126.31M | 107.94M |
| Cost of Revenue | 35.68M | 40.45M | 32.77M | 27.75M | 29.93M |
| Gross Profit | 97.40M | 108.10M | 98.84M | 98.57M | 78.01M |
| Operating Expenses | 112.58M | 119.60M | 114.97M | 110.60M | 96.85M |
| Operating Income | -15.18M | -11.50M | -16.13M | -12.04M | -18.84M |
| EBITDA | -13.28M | -11.50M | -16.53M | -14.49M | -17.23M |
| Interest Expense | 0 | - | 15.00K | 15.00K | 15.00K |
| Pretax Income | -13.28M | -9.46M | -16.55M | -14.51M | -17.24M |
| Tax Provision | 224.00K | 244.00K | 212.00K | 876.00K | 232.00K |
| Net Income | -13.50M | -9.70M | -16.76M | -15.39M | -17.47M |
| Diluted EPS | -1.30 | -0.90 | -1.60 | -1.50 | -1.70 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 563.24M | 537.43M | 515.82M | 539.57M |
| Cost of Revenue | - | 183.20M | 174.21M | 153.42M | 136.65M |
| Gross Profit | - | 380.04M | 363.23M | 362.40M | 402.91M |
| Operating Expenses | - | 1.36B | 1.03B | 684.83M | 457.76M |
| Operating Income | - | -980.41M | -669.32M | -322.43M | -54.84M |
| EBITDA | - | -856.31M | -517.90M | -288.54M | -32.00M |
| Interest Expense | 1.54M | - | 0 | 0 | 30.00K |
| Pretax Income | - | -969.25M | -651.30M | -340.74M | -53.79M |
| Tax Provision | - | 1.99M | 2.39M | 5.88M | 1.56M |
| Net Income | - | -971.23M | -653.69M | -346.63M | -55.35M |
| Diluted EPS | - | -93.50 | -63.80 | -33.70 | -5.10 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 1.59B | 1.04B | 885.30M | 820.38M |
| Current Assets | - | 1.26B | 884.10M | 776.62M | 738.59M |
| Cash & Equivalents | - | 905.45M | 615.10M | 519.85M | 478.39M |
| Inventory | - | 130.32M | 69.02M | 53.76M | 48.58M |
| Receivables | - | 109.95M | 126.86M | 152.01M | 169.61M |
| Total Liabilities | - | 429.13M | 271.59M | 304.48M | 285.11M |
| Current Liabilities | - | 411.45M | 263.36M | 266.30M | 246.98M |
| Long Term Debt | - | - | - | - | 1.70M |
| Total Debt | - | 50.79M | 12.32M | 52.32M | 43.12M |
| Total Equity | - | 1.16B | 768.41M | 580.83M | 535.26M |
| Shares Outstanding | - | 105.67M | 105.46M | 110.64M | 108.21M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -456.81M | -255.78M | -92.26M | -28.44M |
| Investing Cash Flow | - | -7.46M | -9.30M | -4.41M | -4.39M |
| Financing Cash Flow | - | -86.24M | -48.83M | -72.00K | 1.90M |
| Capital Expenditure | - | -70.47M | -9.38M | -5.98M | -5.25M |
| Free Cash Flow | - | -527.28M | -265.17M | -98.24M | -33.69M |
| Net Change in Cash | - | -550.51M | -313.92M | -96.75M | -30.93M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 67.5% | 67.6% | 70.3% | 74.7% |
| Operating Margin % | - | -174.1% | -124.5% | -62.5% | -10.2% |
| Net Margin % | - | -172.4% | -121.6% | -67.2% | -10.3% |
| ROE % | - | -83.8% | -85.1% | -59.7% | -10.3% |
| ROCE % | - | -83.4% | -86.2% | -52.1% | -9.6% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BNR
Burning Rock Biotech (BNR) Edges Higher as Biotech Sentiment Stabilizes - Breakout Trade - dars.gov.et
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxNajE5dXhwTWoxSk1hVlBqaGNLVTRzRlVIb1UzbVh6WGg3WGRCWkM0M1NHR2RtU3diYVZjWEFZN0VaVW1UQ1RzcXU2MDFDOHB5MF9BWnB5aWxLZWo2T1pFN1BlQkplVTkwS0ZwMjM3MkozLVljeEliN013RW1wLVM0Zl9OcmR4UXcxYzdVNn…
Burning Rock Founder and CEO Yusheng Han Purchases 73,141 ADSs in Open Market, Bringing Total to 145,874 Across Three Post-Earnings Windows - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiigJBVV95cUxPRXZkcTNrS0J0eDVvdHBFanRsUTd0NGYyN1JiN2FFTTIwczFvcHZZZHhrZ1hVOWFScTl4OTRnU2JJS24wRlNjZDBlcWFyS0ZTeDREc3lQcGFvNUZORTFfVDQ1cFlYSVpIVGM0WEw2WVRxU1RlTHVLb2pyVi1YeElJM0p6WFFvWWgyM1QyOD…
Burning Rock Biotech Ltd (BNR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
<a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE1LRzRqUVREeS04VEZVenlqQVAySk9jUE50RlI0bDE3cnBmellGN0JBdXAyVDhuM2NqbkFaOEtnRDJ3ZGdxQV9xbmIwb0djanBZYVY1Zmx5UUk1N2ZDMWRoY2g1NFEzdkdvUVdTYjluUQ?oc=5" target="_blank">Burning Rock Biot…
Responsive Playbooks and the BNR Inflection - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxNYWJoVkJaaTFadEl0RjVNNXlXNUpSblB1VWFQZ25fRG1iNUFpZjdmODloV2Nmc29YR0FCMWhxb25FUWhGRXEtdS1RLVRNcDg0RHh2WkcxX2l6cDJwMDhYWDJ1TGxUV1dGeXJqWnFlQ3RkbnloVmJWTm5wc1dUWmZ5RHZSTXppZUc0TDBCd0…
Is Brenntag (XTRA:BNR) Prioritizing Income Over Profitability With Its Dividend Amid Weaker Earnings? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxQb2dKWUNIRU02VnBVRVRmS25ZX0lQVVVYZWp1Z1Y0Q1cweG55TEozR0VWcE1veFZLOGFrMzBzaHRJaTV5dUZuMjhKbVdjZTZRQWVCNWZqamRjdlFLYkNzXzRvajJZVUpnWnBTUEwtNWxWSHFKcThXY052OE1sZ2JsT3Z2SGtRUHZYUEdaU2…
Why These High-Flying Stocks Came Back To Earth - Benzinga
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxNY0tBTmpMeDVSMFFLaTZUbXctb3dxcENMNVRTNWFCbS12Y0lCUVBfVGxZdU5hd3BIeXl5R1pFTFFzV1ZYeHUwYW9GMDkzX05lSEhWT01lTmlYS0NXNC03UGpzRW42ZWxxY1YtN0NXa0FnX1dNRVZLYWRCUHctUzljMWFqSTlhYm1xWm93WH…
BNR — Frequently Asked Questions
What is the current share price of BNR?
As of 2026-08-05 17:25 PDT, BNR trades at $8.88 on NASDAQ/NYSE. Its 52-week range is $6.10 to $41.06.
What is the market capitalisation of BNR?
BNR has a market capitalisation of $960.87M on NASDAQ/NYSE.
What is the P/E ratio of BNR?
BNR trades at a trailing price-to-earnings (P/E) ratio of -1.74. Its price-to-book (P/B) ratio is 1.80.
What is the return on equity (ROE) of BNR?
BNR has a return on equity (ROE) of -10.34%. Its return on capital employed (ROCE) is -9.56%.
Is BNR a good stock to buy?
This page provides a data-driven analysis of BNR, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.